Analysis of Clinical Trials of New Drugs for Liver Diseases in China.

ABSTRACT:

Background

Liver diseases are a major public health concern worldwide, and the development of novel therapeutic drugs is an important research focus. But no overview has been conducted so far on the current research and development for liver-specific drugs in China, and the actual situation regarding the development and evaluation of new drugs in clinical trials.

Methods

The information of all clinical trials on liver diseases were obtained through the "Pharmaceutical Clinical Trial Registration and Information Disclosure Platform" before December 31, 2020.

Results

A total of 751 clinical trials on liver disease-related drugs were published on the above platform, including 574 chemical drugs, 128 biological products, and 49 traditional Chinese medicine (TCM)/natural d

SUBMITTER: Lin L 

PROVIDER: S-EPMC8312514 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature